Abdulla Damluji Highlights ASPREE Trial Update
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared an insightful thread on X:
“Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial: ESC Journals
Aspirin for primary prevention for older pts = MACE! ”
Read the full article here.
Title: Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial
Authors: Rory Wolfe, Jonathan C Broder, Zhen Zhou, Anne M Murray, Joanne Ryan, Andrew T Chan, Mark R Nelson, Robyn L Woods, Michael E Ernst, Suzanne G Orchard, Brenda Kirpach, Christopher M Reid, Raj C Shah, Nigel Stocks, Karen L Margolis, Johannes T Neumann, Michelle Wilson, Sharyn Fitzgerald, Suzanne E Mahady, Erica M Wood, Shara Ket, Charles B Eaton, Peter Hand, Mobin Malik, Walter P Abhayaratna, Prasanna Venkataraman, Peter Chan, Geoffrey C Cloud, Geoffrey A Donnan, Jeff D Williamson, Andrew M Tonkin
Stay updated with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia